Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3572254rdf:typepubmed:Citationlld:pubmed
pubmed-article:3572254lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:3572254lifeskim:mentionsumls-concept:C0006104lld:lifeskim
pubmed-article:3572254lifeskim:mentionsumls-concept:C0204727lld:lifeskim
pubmed-article:3572254lifeskim:mentionsumls-concept:C0205409lld:lifeskim
pubmed-article:3572254lifeskim:mentionsumls-concept:C0205307lld:lifeskim
pubmed-article:3572254lifeskim:mentionsumls-concept:C0061099lld:lifeskim
pubmed-article:3572254lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:3572254pubmed:issue3lld:pubmed
pubmed-article:3572254pubmed:dateCreated1987-6-9lld:pubmed
pubmed-article:3572254pubmed:abstractTextA sialidase-susceptible monosialoganglioside was isolated from normal human brain by DEAE-Sephadex A-25 and Iatrobeads column chromatography. The yield of this ganglioside was about 6 mg per whole brain. Its structure was elucidated by sugar analysis, sialidase digestion, permethylation, and proton NMR studies. This ganglioside had carbohydrate, fatty acid, and long-chain base compositions identical to those of brain GM1a. However, the sialosyl residue was found to be linked (alpha 2-3) to the terminal galactosyl residue of the asialo-GM1a backbone. The complete structure of this ganglioside was therefore identified as GM1b or IV3NeuAcGgOse4Cer.lld:pubmed
pubmed-article:3572254pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3572254pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3572254pubmed:languageenglld:pubmed
pubmed-article:3572254pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3572254pubmed:citationSubsetIMlld:pubmed
pubmed-article:3572254pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3572254pubmed:statusMEDLINElld:pubmed
pubmed-article:3572254pubmed:monthMarlld:pubmed
pubmed-article:3572254pubmed:issn0022-2275lld:pubmed
pubmed-article:3572254pubmed:authorpubmed-author:YuR KRKlld:pubmed
pubmed-article:3572254pubmed:authorpubmed-author:ArigaTTlld:pubmed
pubmed-article:3572254pubmed:issnTypePrintlld:pubmed
pubmed-article:3572254pubmed:volume28lld:pubmed
pubmed-article:3572254pubmed:ownerNLMlld:pubmed
pubmed-article:3572254pubmed:authorsCompleteYlld:pubmed
pubmed-article:3572254pubmed:pagination285-91lld:pubmed
pubmed-article:3572254pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:3572254pubmed:meshHeadingpubmed-meshheading:3572254-...lld:pubmed
pubmed-article:3572254pubmed:meshHeadingpubmed-meshheading:3572254-...lld:pubmed
pubmed-article:3572254pubmed:meshHeadingpubmed-meshheading:3572254-...lld:pubmed
pubmed-article:3572254pubmed:meshHeadingpubmed-meshheading:3572254-...lld:pubmed
pubmed-article:3572254pubmed:meshHeadingpubmed-meshheading:3572254-...lld:pubmed
pubmed-article:3572254pubmed:meshHeadingpubmed-meshheading:3572254-...lld:pubmed
pubmed-article:3572254pubmed:meshHeadingpubmed-meshheading:3572254-...lld:pubmed
pubmed-article:3572254pubmed:meshHeadingpubmed-meshheading:3572254-...lld:pubmed
pubmed-article:3572254pubmed:year1987lld:pubmed
pubmed-article:3572254pubmed:articleTitleIsolation and characterization of ganglioside GM1b from normal human brain.lld:pubmed
pubmed-article:3572254pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3572254pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed